Assertio Therapeutics Inc.
- UEI
- KQUEM2JQVLV5
- CAGE
- 4L3F5
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- assertiotx.com
- Founded
- 1995
- Employees
- 51-250
- Estimated annual revenue
- $50M-$100M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Prolastin drug for VA patients | Veterans Integrated Service Network 20 (VHA) | $4,869 |
Quick answers
Is Assertio Therapeutics Inc. registered in SAM.gov?
Assertio Therapeutics Inc.'s SAM.gov registration expired on March 10, 2026.
What is Assertio Therapeutics Inc.'s CAGE code?
Assertio Therapeutics Inc.'s CAGE code is 4L3F5, and its Unique Entity ID (UEI) is KQUEM2JQVLV5.
Which contract vehicles does Assertio Therapeutics Inc. hold?
Assertio Therapeutics Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Assertio Therapeutics Inc.'s most recent federal award?
Assertio Therapeutics Inc.'s most recent federal contract award is Prolastin drug for VA patients (VA663A10324), from Veterans Integrated Service Network 20 (VHA), on February 17, 2011.
On GovTribe
See Assertio Therapeutics Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors